EVIO (EVIO) Total Receivables: $0.65 Mil (As of Jun. 2020)


What is EVIO Total Receivables?

EVIO EVIO -98.00% Total Receivables is $0.65 Mil as of Jun. 2020.

EVIO's Total Receivables for the quarter that ended in Jun. 2020 was $0.65 Mil.

EVIO Total Receivables Historical Data

* Premium members only.

The historical data trend for EVIO's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EVIO Total Receivables Chart

EVIO Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19
Total Receivables
0.01 0.03 0.33 0.33 0.67

EVIO Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.67 0.73 0.71 0.65

EVIO Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $0.65 Mil mean?
EVIO (EVIO) has a Total Receivables of $0.65 Mil as of Jun. 2020. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on EVIO and its competitors.
Is EVIO's Total Receivables too high?
EVIO's current Total Receivables is $0.65 Mil.
How does EVIO's Total Receivables compare to VCBD and ACCA?
EVIO's Total Receivables of $0.65 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on EVIO and its competitors. EVIO's current Total Receivables is $0.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EVIO stock overvalued right now?
EVIO (EVIO) has a current Total Receivables of $0.65 Mil. The current Total Receivables is $0.65 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For EVIO (EVIO), the current Total Receivables is $0.65 Mil as of Jun. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EVIO Business Description

Address 2654 W. Horizon Ridge Drive Parkway, Suite B5-208, Henderson, NV, USA, 89052
EVIO Inc is a Colorado corporation and a diversified holding company. Its subsidiaries provide analytical testing and advisory services to the emerging legalized cannabis industry. The Company performs analytical testing for cannabis and cannabis-derived products, including hemp and CBD products. Its current operations also include pharmaceutical, environmental, stability, and analytical testing, as well as residential and commercial construction and investments, with operations in the United States and Canada.